Presently, 260 Drug Candidates Are Being Evaluated In Clinical / Preclinical Stages For The Treatment Of A Wide Variety Of Disease Indications; The US Has Emerged As The Major Hub For Microbiome-based Research

>

Presently, 260 drug candidates are being evaluated in clinical / preclinical stages for the treatment of a wide variety of disease indications; the US has emerged as the major hub for microbiome-based research

The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic has been officially approved by an authorized medical product regulator. However, the current development pipeline of microbiome therapeutics has several promising candidates that are likely to result in commercial success stories soon.

 

To order this 640+ page report, which features 235+ figures and 275+ tables, please visit this link

 

The USD 4 billion (by 2030) financial opportunity within the microbiome therapeutics (Tx) market and diagnostics (Dx) markets, has been analyzed across the following segments:

  • Type of Therapy (Tx)
  • Prescription Drug
  • Prebiotics
  • Probiotics

 

  • Type of Molecule (Tx)
  • Small Molecules
  • Biologics

 

  • Target Indication (Tx+Dx)
  • Acne Vulgaris
  • Atopic Dermatitis
  • Clostridium difficile Infection
  • Colorectal Cancer
  • Crohn’s Disease
  • Diabetes
  • Irritable Bowel Syndrome
  • Lactose Intolerance
  • Lung Cancer
  • Nonalcoholic steatohepatitis (NASH)
  • Obesity
  • Ulcerative colitis

 

  • Therapeutic Area (Tx+Dx)
  • Autoimmune Disorders
  • Dental Disorders
  • Digestive and Gastrointestinal Disorders
  • Dermatological Disorders
  • Infectious Disease
  • Metabolic Disorders
  • Oncology
  • Others

 

  • Key Geographical Regions (Tx+Dx)
  • North America
  • Europe
  • Asia-Pacific and Rest of the World

 

 

The Human Microbiome Market, 2019-2030 report features the following companies, which we identified to be key players in this domain:

  • 4D Pharma
  • Armata Pharmaceuticals
  • Evelo Biosciences
  • Rebiotix (Acquired by Ferring Pharmaceuticals)
  • Seres Therapeutics
  • Vedanta Biosciences

 

Table of Contents

  1. Preface

 

  1. Executive Summary

 

  1. Introduction

 

  1. Microbiome Therapeutics: Market Landscape

 

  1. Company and Drug Profiles

 

  1. Microbiome Diagnostics: Market Landscape

 

  1. Fecal Microbiota Therapy (FMT)

 

  1. Attractiveness Competitiveness (AC) Matrix

 

  1. Microbiome Related Initiatives of Big Pharmaceutical Players

 

  1. Start-up Health Indexing

 

  1. Key Therapeutics Areas

 

  1. Funding and Investment Analysis

 

  1. Contract Services for Microbiome Therapeutics

 

  1. Big Data and Microbiome Therapeutics

 

  1. Microbiome Therapeutics: Market Forecast and Opportunity Analysis

 

  1. Microbiome Diagnostics: Market Forecast and Opportunity Analysis

 

  1. Fecal Microbiota Therapies: Market Forecast and Opportunity Analysis

 

  1. Case Study: Microbiome-based Products in Other Industries

 

  1. Concluding Remarks

 

  1. Executive Insights

 

  1. Appendix I: Tabulated Data

 

  1. Appendix II: List of Companies and Organizations

 

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com 

 

Share:

Keywords: healthcare,roots analysis,wellness and fitness,information services,market research,research,medical devices,pharma,pharmaceutical,active pharmaceutical ingredient,pharmaceutical product development inc

Comments

Other related blogs

A Complete Guide for Pregnancy Termination Kit

By : Safeabortionpharma

Women across the world may or may not be aware of the pregnancy and its care. Pregnancy is the stage..


The benefits of CBD Products

By : THE CBD BLOGS

CBD is perhaps the most broadly utilized wellbeing and health items in America, and however numerous..


The microbial contract biomanufacturing market is projected to be worth USD 9.3 billion by 2030, growing at a CAGR of 8.7%, claims Roots Analysis

By : Roots Analysis

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragme..


How IV Hydration Therapy in Desert Hot Springs CA Overcomes Hangovers

By : Sungh Yuna

Hangovers after a fun night in California can make your morning uncomfortable and give you a painful..